Although for some time now many thought Merck was an easy short, given Vioxx and the large number of law suits and settlements before it, the company had a strategy in place to rise again. And,...
More than three years after the Vioxx news first broke, there is more and more bad news for Merck as it now seems that the drug was even worse than first disclosed. Plus, Merck is now losing...
Steve Nissen is a very smart man- I have heard him speak many times at various cardiology meetings. He is one of the few prominent researchers who hasn't been bought off by big pharma. As such...
It looks like Merck has shot themselves in the foot again. Once again, a study that they funded shows an increased risk in Vioxx. They clearly are going to have increased Vioxx liability now -...
BestCashCow provides information on the best CD (certificates of deposit) rates, the best money market rates, the best savings rates, and more - as well as financial information that can help you make better decisions with your money.